Welcome to our dedicated page for Mgp Ingredients news (Ticker: MGPI), a resource for investors and traders seeking the latest updates and insights on Mgp Ingredients stock.
MGP Ingredients, Inc. (MGPI) combines heritage distilling with innovative food ingredient solutions, serving both premium beverage and functional food markets. This news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and operational milestones.
Access official press releases and curated news coverage spanning MGPI's distilled spirits innovations and specialty wheat protein advancements. Track updates including earnings reports, production expansions, product launches, and strategic partnerships across both business segments.
Our repository features essential announcements related to bourbon/rye whiskey production, non-GMO ingredient developments, facility upgrades, and market leadership in alcohol purification technologies. Content is organized chronologically for efficient tracking of the company's progress in both traditional and modern food sectors.
Bookmark this page for direct access to MGPI's latest regulatory filings, leadership updates, and sustainability initiatives. Check regularly for insights into how the company maintains its position at the intersection of craft beverage trends and nutritional food innovation.
MGP Ingredients (MGPI), a leading provider of branded and distilled spirits and food ingredient solutions, has announced a quarterly dividend payment. The company's board of directors has declared a dividend of $0.12 per share of common stock. Shareholders who are recorded as stockholders by May 16, 2025, will receive the dividend payment on May 30, 2025.
MGP Ingredients has successfully enhanced its financial flexibility through a significant credit facility expansion. The company has increased its revolving credit facility from $400 million to $500 million and extended its maturity from 2026 to 2030, maintaining current interest rates.
Key improvements include:
- Accordion feature increased from $100 million to $200 million
- Extension of shelf agreement for issuing up to $250 million in senior secured promissory notes to 2028
- Partnership with Wells Fargo Bank-led syndicate of lenders and PGIM (Prudential) affiliates
The refinancing strengthens MGP's balance sheet and cash flows, positioning the company to execute its strategic objectives and drive shareholder returns. As a leading provider of branded and distilled spirits and food ingredient solutions, this financial enhancement supports MGP's continued growth trajectory.
El Mayor Tequila announces a significant packaging update across its product line, transitioning to a new 750 mL slim bottle design throughout 2025. The redesign features a larger label to create a more unified brand appearance and enhance shelf visibility.
The premium tequila, produced at Destiladora Gonzalez Lux in Arandas, Mexico, is crafted from 100% estate-grown Blue Weber Agave from Jalisco. The portfolio includes Blanco, Reposado, Rosado Reposado, Añejo, Extra Añejo, and Cristalino varieties, each with distinct aging processes and flavor profiles.
The brand has received notable recognition, including gold medals at the ASCOT and SIP Awards for its Blanco, a double gold at the San Francisco World Spirits Competition for Reposado, and a double platinum at ASCOT Awards for Añejo. El Mayor Reposado was also named among the top 10 tequilas globally at the 2025 International Wines and Spirits Competition.
MGP Ingredients (MGPI), a leading provider of branded and distilled spirits and food ingredient solutions, has scheduled its first quarter 2025 financial results announcement for Thursday, May 1, 2025 at 10 a.m. ET. The company will release its financial results for the quarter ended March 31, 2025, before market open.
The earnings conference call will feature Brandon Gall, interim President and CEO, and Mark Davidson, Corporate Controller and Head of Treasury. Investors can access the live webcast through the company's Investor Relations website or dial in directly using 844-308-6398 (domestic) or 412-717-9605 (international).
MGP Ingredients (MGPI) has announced the appointment of two new independent directors to its Board: Gerardo 'Gerry' Lopez and Martin Roper, while Preet Michelson has resigned from the Board. Following these changes, the Board will maintain nine directors, with eight being independent.
Lopez brings significant executive experience as former President and CEO of AMC Entertainment Holdings and EVP at Starbucks Coffee Company. He currently serves on the boards of CBRE Group, Newell Brands, and Realty Income Roper is the current CEO of Vita Coco Company and serves on Fintech's board, with previous experience as CEO of The Boston Beer Company.
Board Chairman Donn Lux expressed confidence that the new directors' industry knowledge and operational expertise will help guide MGPI's next growth phase and strategic priorities.
Luxco has announced the launch of Escasa, a new ultra-premium sipping Tequila, available nationwide. The portfolio includes Blanco, with Reposado set to release in summer 2025.
Fourth-generation Master Distiller Graciela "Grace" Gonzalez crafts Escasa using:
- Hand-selected 100% Blue Weber agave from different single estates yearly
- Triple-distillation process
- Extra pure water, mature single estate-grown agave
- Heirloom yeast and Bagazo fibers for enhanced depth during fermentation
The upcoming Reposado variant will be uniquely aged in Albariño wine barrels from Rias Baixas, Spain, marking a first-of-its-kind aging process in the tequila industry.
Lux Row Distillers announces the release of Blood Oath Pact 11 Kentucky Straight Bourbon Whiskey, finished in Añejo tequila barrels. This edition blend combines a 14-year ryed bourbon, a 10-year wheated bourbon, and a 7-year ryed bourbon finished in Añejo tequila barrels, bottled at 98.6 proof (49.3% ABV).
The release is to 51,000 bottles, with 17,000 cases arriving at retail in April 2025 at a suggested price of $129.99 per 750mL bottle. The bourbon features vanilla, black pepper, cherry, and citrus notes, finishing with black cherry and dark chocolate flavors. In-person purchases will be available at Lux Row Distillers in Bardstown, Kentucky on April 26, to one bottle per customer.
Of the total allocation, 1,400 bottles will be reserved for a future Trilogy release, continuing the tradition of previous Blood Oath Trilogy collections launched in 2018, 2021, and 2023.
Yellowstone Bourbon has launched Small Batch 107, a new permanent addition to its portfolio. This six-year-aged bourbon, bottled at 107 proof, is the brand's first expression with an age statement and one of its highest-proof everyday offerings. The non-chill filtered bourbon features notes of caramel, vanilla, chocolate, oak, honey, and signature cherry notes.
Available nationwide at a suggested retail price of $44.99 per 750mL bottle, Small Batch 107 joins Yellowstone's growing family of seven expressions. The launch pays homage to the brand's history, as Yellowstone was Kentucky's top-selling whiskey in the 1960s when it was bottled at six years old. Master Distiller Stephen Beam crafted this expression to achieve an ideal balance of flavor and depth.
The brand's other expressions have received notable recognition, including Double Gold awards for Yellowstone Select at the 2024 SIP Awards and various accolades for their Special Finishes Collection.
MGP Ingredients (Nasdaq:MGPI), a leading provider of branded and distilled spirits and food ingredient solutions, has announced its participation in the upcoming 37th Annual Roth Conference. Brandon Gall, serving as Interim President and CEO, and CFO, along with Amit Sharma, VP of IR, will represent the company in a fireside chat scheduled for March 17, 2025, at 4:30 p.m. Eastern.
Investors and interested parties can access the live webcast through the 'News & Events' section on MGP's investor relations website at ir.mgpingredients.com/news-events. A replay of the presentation will be made available on the company's website following the conclusion of the event.